These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 22880138)

  • 1. Administration of triclabendazole is safe and effective in controlling fascioliasis in an endemic community of the Bolivian Altiplano.
    Villegas F; Angles R; Barrientos R; Barrios G; Valero MA; Hamed K; Grueninger H; Ault SK; Montresor A; Engels D; Mas-Coma S; Gabrielli AF
    PLoS Negl Trop Dis; 2012; 6(8):e1720. PubMed ID: 22880138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triclabendazole in the treatment of human fascioliasis: a community-based study.
    el-Morshedy H; Farghaly A; Sharaf S; Abou-Basha L; Barakat R
    East Mediterr Health J; 1999 Sep; 5(5):888-94. PubMed ID: 10983527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of human chronic fascioliasis with triclabendazole: drug efficacy and serologic response.
    Apt W; Aguilera X; Vega F; Miranda C; Zulantay I; Perez C; Gabor M; Apt P
    Am J Trop Med Hyg; 1995 Jun; 52(6):532-5. PubMed ID: 7611560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass Drug Administration of Triclabendazole for
    Mollinedo S; Gutierrez P; Azurduy R; Valle F; Salas A; Mollinedo Z; Soto P; Villarroel CF; Ransom J; Lawrence R; Berman J; Soto J
    Am J Trop Med Hyg; 2019 Jun; 100(6):1494-1497. PubMed ID: 31115295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of two single-day regimens of triclabendazole for fascioliasis in Peruvian children.
    Maco V; Marcos L; Delgado J; Herrera J; Nestares J; Terashima A; Samalvides F; Gotuzzo E
    Rev Soc Bras Med Trop; 2015; 48(4):445-53. PubMed ID: 26312936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fascioliasis in relatives of patients with Fasciola hepatica infection in Peru.
    Marcos L; Maco V; Terashima A; Samalvides F; Espinoza JR; Gotuzzo E
    Rev Inst Med Trop Sao Paulo; 2005; 47(4):219-22. PubMed ID: 16138205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human fascioliasis successfully treated with triclabendazole.
    Laird PP; Boray JC
    Aust N Z J Med; 1992 Feb; 22(1):45-7. PubMed ID: 1580862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy and tolerability of triclabendazole in Cuban patients with latent and chronic Fasciola hepatica infection.
    Millán JC; Mull R; Freise S; Richter J;
    Am J Trop Med Hyg; 2000; 63(5-6):264-9. PubMed ID: 11421375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized trial of a single, double and triple dose of 10 mg/kg of a human formulation of triclabendazole in patients with fascioliasis.
    Talaie H; Emami H; Yadegarinia D; Nava-Ocampo AA; Massoud J; Azmoudeh M; Mas-Coma S
    Clin Exp Pharmacol Physiol; 2004 Nov; 31(11):777-82. PubMed ID: 15566392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triclabendazole Treatment Failure for Fasciola hepatica Infection among Preschool and School-Age Children, Cusco, Peru
    Morales ML; Tanabe MB; White AC; Lopez M; Bascope R; Cabada MM
    Emerg Infect Dis; 2021 Jul; 27(7):1850-1857. PubMed ID: 34152949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of formulations of triclabendazole and ivermectin in combination against liver fluke (Fasciola hepatica) and gastro-intestinal nematodes in cattle and sheep and sucking lice species in cattle.
    Stevenson CR; Mahoney RH; Fisara P; Strehlau G; Reichel MP
    Aust Vet J; 2002 Nov; 80(11):698-701. PubMed ID: 12465830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment Failure after Multiple Courses of Triclabendazole among Patients with Fascioliasis in Cusco, Peru: A Case Series.
    Cabada MM; Lopez M; Cruz M; Delgado JR; Hill V; White AC
    PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004361. PubMed ID: 26808543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of artemether in the treatment of chronic fascioliasis in Egypt: exploratory phase-2 trials.
    Keiser J; Sayed H; el-Ghanam M; Sabry H; Anani S; el-Wakeel A; Hatz C; Utzinger J; el-Din SS; el-Maadawy W; Botros S
    PLoS Negl Trop Dis; 2011 Sep; 5(9):e1285. PubMed ID: 21909440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of very high prevalence and intensity of infection with Fasciola hepatica among Aymara children from the Northern Bolivian Altiplano.
    Esteban JG; Flores A; Aguirre C; Strauss W; Angles R; Mas-Coma S
    Acta Trop; 1997 Jun; 66(1):1-14. PubMed ID: 9177091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anthelmintic efficacy of triclabendazole against Fasciola hepatica in sheep.
    Turner K; Armour J; Richards RJ
    Vet Rec; 1984 Jan; 114(2):41-2. PubMed ID: 6719804
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of an injectable combination anthelmintic (nitroxynil+clorsulon+ivermectin) against early immature Fasciola hepatica compared to triclabendazole combination flukicides given orally or topically to cattle.
    Hutchinson GW; Dawson K; Fitzgibbon CC; Martin PJ
    Vet Parasitol; 2009 Jun; 162(3-4):278-84. PubMed ID: 19375232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A praziquantel-ineffective fascioliasis case successfully treated with triclabendazole.
    Ishii Y; Nakamura-Uchiyama F; Nawa Y
    Parasitol Int; 2002 Jun; 51(2):205-9. PubMed ID: 12113760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of triclabendazole (Fasinex) against immature and adult Fasciola hepatica in experimentally infected cattle.
    Shi FH; Lin BF; Qian CG; Li M; Fang MB; Ma JL; Shen W; Wang SW; Jian XL
    Vet Parasitol; 1989 Sep; 33(2):117-24. PubMed ID: 2800300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Outbreak of Human Fascioliasis gigantica in Southwest China.
    Chen JX; Chen MX; Ai L; Xu XN; Jiao JM; Zhu TJ; Su HY; Zang W; Luo JJ; Guo YH; Lv S; Zhou XN
    PLoS One; 2013; 8(8):e71520. PubMed ID: 23951181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative efficacy of closantel and triclabendazole against Fasciola hepatica in experimentally infected sheep.
    Maes L; Vanparijs O; Lauwers H; Deckers W
    Vet Rec; 1990 Nov; 127(18):450-2. PubMed ID: 2275080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.